# GASTO-1098 (NCT06139419)

> The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06139419
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: Sun Yat-sen University
- Conditions: Non-small Cell Lung Cancer
- Interventions: definitive radiotherapy; induction chemo-immunotherapy; concurrent chemotherapy; Immunotheapy consolidation; Thymosin Alpha1
- Enrollment: 114
- Primary outcome: Completion rate of immunotherapy

## Indexed commentary on GASTO-1098 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=gasto-1098-nct06139419